XML 36 R26.htm IDEA: XBRL DOCUMENT v3.23.1
Note - 4 Related Party Transactions (Details Textual) - USD ($)
3 Months Ended
Mar. 24, 2022
Mar. 31, 2023
Mar. 31, 2022
Jan. 31, 2023
Dec. 31, 2022
Mar. 31, 2017
Amortization of Debt Discount (Premium)   $ 3,472,000 $ 213,000      
Interest Paid, Excluding Capitalized Interest, Operating Activities   140,000 60,000      
ImmuneCyte [Member]            
Percent of Ownership Interest Transferred 8.64%          
Royalty, Percent of Annual Net Sales, US Patents 7.50%          
Royalty, Percent of Annual Net Sales, Other Licensed Intellectual Property 5.00%          
Revolving Credit Facility [Member] | Boyalife Asset Holding II [Member]            
Line of Credit Facility, Maximum Borrowing Capacity           $ 10,000,000
Long-Term Line of Credit   $ 7,278,000        
Debt Instrument, Interest Rate, Stated Percentage   22.00%     22.00%  
Debt Instrument, Convertible, Conversion Price   $ 2.65   $ 6.30 $ 6.30  
Share Price (in dollars per share)   $ 2.65   $ 2.87    
Debt Instrument, Unamortized Discount   $ 779,000   $ 2,350,000 $ 1,223,000  
Amortization of Debt Discount (Premium)   3,604,000 213,000      
Interest Paid, Excluding Capitalized Interest, Operating Activities   389,000 $ 550,000      
Interest Payable   111,000     $ 1,492,000  
Revolving Credit Facility [Member] | Boyalife Asset Holding II [Member] | Incremental Value Increase [Member]            
Debt Instrument, Unamortized Discount   $ 810,000